Synthesis and evaluation of (+) and (−)‐2,2‐difluorocitrate as inhibitors of rat‐liver ATP‐citrate lyase and porcine‐heart aconitase

Barbara A. SAXTY, Riccardo NOVELLI, Roland E. DOLLE, Lawrence I. KRUSE, David G. REID, Patrick CAMILLERI, Timothy N.C. WELLS

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

The enantiomers (+) and (−)‐2,2‐difluorocitrate have been synthesized. Both are good inhibitors of ATP‐citrate lyase, showing competitive inhibition against citrate, with Kis= 0.7 μM for (+)‐2,2‐difluorocitrate and 3.2 μM for (−)‐2,2‐difluorocitrate. The inhibition patterns with either ATP or CoA as the varied substrate were uncompetitive and mixed, respectively, but with much weaker inhibition constants. Neither isomer undergoes carbon‐carbon bond cleavage as a substrate and there is no evidence of irreversible time‐dependent inactivation. When ATP‐citrate lyase is incubated with CoA and difluorocitrate, the maximal intrinsic ATPase rate is 10% of the citrate‐induced rate for the (+)‐enantiomer and 2% for the (−)‐enantiomer. 19F‐NMR studies confirm that only the (+)‐enantiomer is chemically processed. The effects of the difluorocitrate enantiomers on the reaction catalysed by aconitase were examined. (−)‐2,2‐Difluorocitrate is a competitive inhibitor against citrate (Kis= 1.5 μM), whereas the (+)‐enantiomer is a relatively poor mixed inhibitor (Ki > 300 μM). The (−)‐enantiomer irreversibly inactivates aconitase at 1.1 min‐1· mM‐1 at 25°C and pH 7.4, whereas no irreversible inhibition is seen with the (+)‐enantiomer. Therefore, it would be expected that the (+)‐enantiomer would slow the rate of acetyl‐CoA synthesis in vivo, without inhibiting the citric acid cycle.

Original languageEnglish
Pages (from-to)889-896
Number of pages8
JournalEuropean Journal of Biochemistry
Volume202
Issue number3
DOIs
StatePublished - Dec 1991
Externally publishedYes

Fingerprint Dive into the research topics of 'Synthesis and evaluation of (+) and (−)‐2,2‐difluorocitrate as inhibitors of rat‐liver ATP‐citrate lyase and porcine‐heart aconitase'. Together they form a unique fingerprint.

Cite this